These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3032700)

  • 1. [Influence of endogenous renin-angiotensin system on plasma aldosterone responsiveness to metoclopramide].
    Iwasaki Y
    Nihon Naibunpi Gakkai Zasshi; 1987 Feb; 63(2):123-32. PubMed ID: 3032700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
    Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR
    Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
    Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
    Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
    Witzgall H; Lorenz R; von Werder K; Weber PC
    Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of metoclopramide, a dopamine inhibitor, on aldosterone secretion in patients with primary aldosteronism].
    Mizuno K; Yaginuma K; Yamazaki M; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1982 Aug; 58(8):976-83. PubMed ID: 6292008
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopaminergic regulation of aldosterone secretion: assessment in different subtypes of primary aldosteronism and in essential hypertension.
    Veglio F; Pinna G; Rabbia F; Panarelli M; Bisbocci D; Melchio R; Chiandussi L
    J Int Med Res; 1991; 19(1):44-9. PubMed ID: 1850365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
    García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
    Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism.
    Woodland E; Tunny TJ; Hamlet SM; Gordon RD
    Clin Exp Pharmacol Physiol; 1985; 12(3):245-8. PubMed ID: 2992855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels.
    Rossi G; Manunta P; Hamlyn JM; Pavan E; De Toni R; Semplicini A; Pessina AC
    J Hypertens; 1995 Oct; 13(10):1181-91. PubMed ID: 8586810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressor and hormonal responses to intravenous injection of metoclopramide in normotensive and hypertensive patients.
    Kawabe H; Suzuki H; Itaya Y; Saruta T
    Jpn J Med; 1990; 29(2):174-9. PubMed ID: 2232366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic blockade of the renin-angiotensin-aldosterone system: effect of high and low sodium intakes.
    Gordon MB; Moore TJ; Dluhy RG; Williams GH
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):415-25. PubMed ID: 6354522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of verapamil on renin-angiotensin-aldosterone system, urinary 6-keto prostaglandin F1 alpha and aldosterone response to metoclopramide in normal man.
    Zacharieva S; Koev D; Matrozov P; Tcharaktchiev D; Stoeva I; Andonova K
    Acta Physiol Pharmacol Bulg; 1989; 15(4):31-6. PubMed ID: 2634902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.
    Ganguly A; Pratt JH; Weinberger MH; Grim CE; Fineberg NS
    J Clin Endocrinol Metab; 1983 Aug; 57(2):388-92. PubMed ID: 6306041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of metoclopramide and dopamine on aldosterone secretion in cultured adrenocortical adenoma cells and adjacent non-adenoma cells from patients with primary aldosteronism].
    Yanase T; Nawata H; Higuchi K; Kato K; Ibayashi H
    Nihon Naibunpi Gakkai Zasshi; 1985 Jun; 61(6):631-41. PubMed ID: 4054405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of aldosterone secretion by metoclopramide is not affected by chronic converting enzyme inhibition.
    Dupont AG; Vanderniepen P; Smitz JJ; Six RO
    Eur J Clin Pharmacol; 1985; 29(2):207-10. PubMed ID: 3000795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma renin activity and aldosterone concentration in sodium-depleted cattle following ACTH or metoclopramide injection.
    Riad F; Giry J; Barlet JP
    Reprod Nutr Dev (1980); 1987; 27(1A):21-8. PubMed ID: 3033780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for endogenous dopaminergic control of mineralocorticoids secretion in normal subjects and in patients with hyperaldosteronism.
    Shimizu Y; Hanew K; Sato S; Sasaki A; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1984 Sep; 144(1):33-42. PubMed ID: 6506061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of metoclopramide on the secretion of aldosterone and other adrenocortical steroids.
    Nagahama S; Fujimaki M; Kawabe H; Nakamura R; Saito I; Saruta T
    Clin Endocrinol (Oxf); 1983 Mar; 18(3):287-93. PubMed ID: 6861367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the central effects of dopamine and metoclopramide on aldosterone regulation in the rat.
    Kawabe H; Kondo K; Hayashi M; Fujimaki M; Nagahama S; Saruta T
    Endocrinol Jpn; 1983 Aug; 30(4):543-9. PubMed ID: 6323152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.